Enfuego Therapeutics, Inc.

Pharmaceutical company · Pittsboro, North Carolina, United States

Enfuego Therapeutics, Inc. is a pharmaceutical company headquartered in Pittsboro, North Carolina, United States. Its earliest recorded incorporation is in 2021. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $2.3 million in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $1 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Enfuego Therapeutics at a glance

Typepharmaceutical company
HeadquartersPittsboro, North Carolina, United States
Earliest incorporation on record2021
Employees (self-reported, 2024)2
SEC CIK1866961

What does Enfuego Therapeutics do?

US government research funding

3 SBIR/STTR small-business research awards from US health agencies, $2.3 million in total (2020 to 2024). NIH funding came from the National Cancer Institute.

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $1 million sold (2025).

Frequently asked questions about Enfuego Therapeutics

Where is Enfuego Therapeutics headquartered?

Enfuego Therapeutics, Inc. is headquartered in Pittsboro, North Carolina, United States.

What does Enfuego Therapeutics do?

Enfuego Therapeutics, Inc. is a pharmaceutical company.

When was Enfuego Therapeutics founded?

The earliest incorporation on record for Enfuego Therapeutics, Inc. is in 2021, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences